Endo International(ENDP) announced that one of its operating companies, Par Pharmaceutical, has begun shipping the authorized generic version of Merck’s Noxafil 200 mg/5 mL oral suspension in the U.S.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MRK:
- Bayer motion to dismiss Merck complaint granted in fight over asset deal
- OncoSec announces results from Phase 2 KEYNOTE-695 clinical trial
- Gritstone initiated with an Outperform at Evercore ISI
- FDA grants full approval for Merck’s Keytruda in MSI-H or dMMR tumors
- Merck downgraded to Hold at Societe Generale on Keytruda patent cliff